| Previous Section | Index | Home Page |
25 Mar 2004 : Column 1054W—continued
Health Funding
Mr. Hoyle: To ask the Secretary of State for Health if he will make additional funding available to areas of continued population growth. [157675]
Mr. Hutton: Changes in primary care trust population figures will be taken into account for the next round of allocations. Preparatory work will begin later in the year.
Health Services
Mr. Hoyle: To ask the Secretary of State for Health how much has been spent on (a) cancer care and (b) heart disease in Lancashire in each of the last five years; and how many people from Chorley benefited. [161592]
Miss Melanie Johnson: This information is not collected centrally. Allocation of funding for particular treatments is a matter for the primary care trusts involved.
25 Mar 2004 : Column 1055W
Mr. Hoyle: To ask the Secretary of State for Health if he will make a statement on the future of accident and emergency at Chorley Hospital. [161609]
Miss Melanie Johnson: The Lancashire Teaching Hospitals National Health Service Trust offers a 24 hour accident and emergency service at the Chorley and South Ribble District General Hospital. There are no plans to change this.
Mr. Hoyle: To ask the Secretary of State for Health how many medical beds there have been in Chorley Hospital in each year since 1997. [161588]
25 Mar 2004 : Column 1056W
Miss Melanie Johnson: Information on beds is collected on a provider basis from national health service organisations and not on a constituency basis. Lancashire Teaching Hospitals NHS Trust opened in 2002–03. It was formed from the merger of the following trusts, Chorley and South Ribble NHS Trust (acute services) and Preston Acute Hospitals NHS Trust.
Relevant available Information on beds for the Lancashire Teaching Hospitals NHS Trust and Chorley and South Ribble NHS Trust is shown in the following tables.
| All specialties (excluding day only) | Generaland Acute | Acute | Geriatric | Mental illness | Learning disability | Maternity | Day only | |
|---|---|---|---|---|---|---|---|---|
| 1996–97 | 370 | 267 | 267 | 0 | 81 | 0 | 22 | 15 |
| 1997–98 | 408 | 308 | 282 | 26 | 78 | 0 | 22 | 13 |
| 1998–99 | 397 | 307 | 281 | 26 | 68 | 0 | 22 | 15 |
| 1999–2000 | 410 | 310 | 290 | 20 | 75 | 2 | 22 | 18 |
| 2000–01 | 420 | 320 | 304 | 16 | 74 | 3 | 22 | 20 |
| 2001–02 | 1,228 | 1,066 | 903 | 163 | 70 | 5 | 86 | 48 |
| 2002–03 | — | — | — | — | — | — | — | — |
Source:
Department of Health form KH03
| All specialties (excluding day only) | Generaland Acute | Acute | Geriatric | Mental illness | Learning disability | Maternity | Day only | |
|---|---|---|---|---|---|---|---|---|
| 1996–97 | — | — | — | — | — | — | — | — |
| 1997–98 | — | — | — | — | — | — | — | — |
| 1998–99 | — | — | — | — | — | — | — | — |
| 1999–2000 | — | — | — | — | — | — | — | — |
| 2000–01 | — | — | — | — | — | — | — | — |
| 2001–02 | — | — | — | — | — | — | — | — |
| 2002–03 | 1,156 | 1,073 | 929 | 144 | 0 | 0 | 84 | 45 |
Note:
The table contains the returns for both Chorley and South Ribble Trust and Preston Acute hospitals Trust to reflect the unified services and management structure across the Trusts.
Source:
Department of Health form KH03
Mrs. Curtis-Thomas: To ask the Secretary of State for Health whether there is a diagnostic and treatment centre located in Crosby. [160435]
Miss Melanie Johnson: There are no treatment centres in Crosby. However, a treatment centre is located at the Aintree Hospital National Health Service Trust and one is due to become operational at the Southport and Ormskirk NHS Trust by the end of 2004.
Mrs. Curtis-Thomas: To ask the Secretary of State for Health how much public funding has been spent on health in Crosby in each of the last seven years. [160439]
Miss Melanie Johnson: Public funding and expenditure figures are not collected on a constituency basis. Information is provided by health authority area from 1996–97 to 2001–02 and by strategic health authority area for 2002–03.
The expenditure is the total expenditure by the relevant health authorities for 1996–97 to 2002–03, and includes the commissioner costs of the relevant primary care trusts for 2000–01-to 2002–03.
The information requested is shown in the table.
| Sefton Health Authority | Cheshire and Merseyside Strategic Health Authority | |
|---|---|---|
| 1996–97 | 197,282 | n/a |
| 1997–98 | 179,155 | n/a |
| 1998–99 | 196,688 | n/a |
| 1999–2000 | 225,349 | n/a |
| 2000–01 | 310,887 | n/a |
| 2001–02 | 331,929 | n/a |
| 2002–03 | n/a | 2,755,985 |
2002–03 data remain provisional.
Sources:
1. Health authority audited accounts 1996–97 and 1997–98.
2. Health authority audited summarisation forms 1998–99 to 2001–02.
3. Strategic health authority audited summarisation forms 2002–03.
4. Primary care trust audited summarisation schedules 2000–01 to 2002–03.
25 Mar 2004 : Column 1057W
Healthy Living Programmes
Mr. Burstow: To ask the Secretary of State for Health pursuant to the answer of 7 January 2004, Official Report, column 393W, on healthy living programmes, when the Tavistock Institute evaluation will be (a) completed and (b) published. [159030]
Miss Melanie Johnson: The fieldwork for the Tavistock Institute evaluation is due to be completed in late 2004 with a published report in 2005. Interim findings are already available on the New Opportunities Fund website at www.nof.org.uk.
Household Goods (Chemicals)
Mr. Lazarowicz: To ask the Secretary of State for Health what assessment he has made of the impact on human health of man-made chemicals found in household goods, with particular reference to (a) perfluorinated compounds, (b) phthalates, (c) phenolic compounds and (d) brominated flame retardants; and what measures the Government plans to protect human health against the dangers posed by such chemicals. [159467]
Miss Melanie Johnson: The Existing Substances Regulation (ESR) is European-wide legislation which required any manufacturer or importer of a chemical into the European Union to submit data to the European Commission. Substances were prioritised and have undergone comprehensive risk assessment, addressing both the human health and the environmental hazards and risks. Several chemicals from the phthalate, phenolic compounds, and brominated fire retardant groupings have been assessed, or are currently undergoing risk assessment. Those that have been agreed by Member States are publicly available on the website of the European Chemicals Bureau at http://ecb.jrc.it/existing-chemicals). In a number of cases, cross-European marketing and use restrictions have been introduced as a result of these assessments.
Following the voluntary withdrawal from the market by the major producer of perfluorooctane sulphonate (PFOS), a hazard assessment of this chemical was undertaken under the auspices of the Organisation for Economic Coperation and Development (OECD);this is available on the OECD website at www.oecd.org/dataoecd/23/18/2382880.pdf. This is now being followed up by the United Kingdom with a risk reduction strategy which aims to look at the remaining uses of PFOS and how they can be phased out.
In addition, information on the hazardous properties and the safe use of chemicals in household goods is governed by the Chemicals (Hazard Information and Packaging for supply) Regulations 2002. These Regulations require that manufacturers must assess a chemical product for its health effects. If dangerous, the
25 Mar 2004 : Column 1058W
product must be labelled with a warning symbol and phrases indicating the dangers. The particular chemical(s) which cause the product to be classified must be named on the label. The Regulations also require that all potentially dangerous chemicals supplied to the public must be in packaging that is properly labelled and contains warnings about the potential hazards and giving advice on suitable precautions.
Other regulations for protecting the consumer are the Department of Trade and Industry's General Product Safety Regulations 1994 (GPSR), which implement the EC General Products Safety Directive (92159/EEC) and apply to all consumer products (or aspects of those products) that are not covered by specific European safety legislation. The GPSR requires manufacturers to ensure that products present no risk or only minimal risk compatible with the product's use. In other words, producers must first take steps to reduce the hazard as far as possible, then warn about any residual hazard(s) and give advice about the precautions that consumers should take when using the product.
| Next Section | Index | Home Page |